Halozyme Therapeutics wants to take over Evotec. The US biopharmaceutical company based in San Diego is offering €2 billion for the German drug developer.

Empowering the Future: Using the industrial metaverse for mastering challenges in pharma & biotech.

Lonza, a global contract development and manufacturing organization (CDMO) for the pharmaceutical, biotech, and nutraceutical markets, announced today that it will invest...

Belgium-headquartered pharmaceutical contract development and manufacturing organization (CDMO) Ardena announced plans to expand its bioanalytical services in the...

Germany’s Secarna Pharmaceuticals has appointed Konstantin Petropoulos as CEO. He is stepping up from his previous role as the company’s chief business officer (CBO) and...

Interview with expert Johannes Koch about the most important success factors in engineering and project management.

US drugmaker AbbVie has signed an agreement to acquire biotechnology company Aliada Therapeutics, which develops therapies for central nervous system (CNS) diseases using...

Mestag Therapeutics, a Cambridge, UK-headquartered biotech company working on new insights into fibroblast-immune interactions, has signed a license and collaboration...

Lonza has completed its acquisition of the Genentech large-scale biologics manufacturing site in Vacaville, California, USA, from Roche for $1.2 billion. The deal was...

Interview with Johannes Kabisch (CSO), Joe Heenan (CEO) and Aron Eiermann (CTO), Proteineer